CheckMate 057: Nivolumab Superior to Docetaxel in Previously Treated Advanced Nonsquamous NSCLC

May 29-June 2, 2015; Chicago, Illinois
Results from the CheckMate 057 trial demonstrate superior OS and favorable safety profile with nivolumab vs docetaxel in patients with advanced nonsquamous NSCLC who failed prior platinum-based doublet chemotherapy.
Format: Microsoft PowerPoint (.ppt)
File Size: 657 KB
Released: May 31, 2015

Acknowledgements

Educational grant provided by:
AstraZeneca
Bayer Healthcare Pharmaceuticals, Inc.
Bristol-Myers Squibb
Celgene Corporation
Genentech BioOncology
Incyte
Novartis Pharmaceuticals Corporation

Related Content

Mary Jo Fidler, MD discusses key data in lung malignancies from ASCO 2020 and optimization of therapeutic benefit through management of cancer cachexia syndrome

person default Mary Jo Fidler, MD Released: June 30, 2020

Gain key clinical insights fast, with this short slideset from CCO on new biomarkers critical to lung cancer care today

Leora Horn, MD, MSc, FRCPC Edward S. Kim, MD, FACP Released: June 26, 2020

In this slideset from Clinical Care Options, M. Dror Michaelson, MD, PhD and Robert Motzer, MD highlight key data on the optimal use of immune checkpoint inhibitors for RCC

M. Dror Michaelson, MD, PhD Robert Motzer, MD Released: June 26, 2020

Summary slideset for nurses and pharmacists caring for patients receiving immune checkpoint inhibitors, from CCO.

Stephanie Andrews, MS, ANP-BC Marianne Davies, DNP, CNS, ACNP-BC, AOCNP John Thompson Headshot John A. Thompson, MD Released: June 26, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?